VNRXVolitionRx Limited
0.4169USD-14.59%Mkt Cap: 5.69M $P/E:

VolitionRx Limited, a multi-national epigenetics company, develops blood tests to help detect and monitor a range of cancers, and diseases associated with NETosis in the United States, Europe, and Asia. The company offer…

Key Statistics

Company
Market Cap5.69M $
Enterprise Value13.72M $
Revenue (TTM)2.46M $
Gross Profit2.46M $
Net Income (TTM)-23.36M $
Revenue/Share0.3580 USD
Last Price0.4169 USD
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees75
CountryUS
SectorHealthcare
IndustryMedical Devices
ISIN
Valuation
P/E (Trailing)
P/E (Forward)-0.56
PEG
EV/EBITDA-0.74
EV/Revenue5.58
P/S2.63
P/B-0.12
EPS (TTM)-3.85
EPS (Forward)-0.85
52W Range
0.41420% of range14.80
52W High14.80 USD
52W Low0.4142 USD
Profitability
Gross Margin100.00%
Oper. Margin-1042.50%
EBITDA Margin0.00%
Profit Margin-1352.16%
ROE68.20%
ROA-338.45%
Growth
Revenue Growth-2.00%
Earnings Growth
Cash Flow & Leverage
Operating CF-19.68M $
CapEx (TTM)89.56K $
FCF Margin-342.27%
FCF Yield-147.85%
Net Debt8.62M $
Net Debt/EBITDA-0.46
Balance Sheet
Debt/Equity-0.33
Current Ratio0.30
Quick Ratio0.23
Book Value/Sh-4.0320 USD
Cash/Share0.2040 USD
Dividends
Fwd Div Rate
Trail. Div Rate0.0000 USD
Div. Yield
5Y Avg Yield
Payout Ratio0.00%
Ex-Div Date
Pay Date
Splits
Last Split1:20
Split DateApr 28, 2026
Analyst Consensus
Rating1.6 (Buy)
Strong BuyBuyHoldSellStr. Sell
Target (Mean)20.21 USD
Upside (mean)+4747.1%
Target Range16.83 USD24.00 USD
$16.83+4747.1% to mean$24.00
# Analysts4
Ownership
Shares Out.13.65M
Float10.91M
Insiders7.32%
Institutions23.61%
Short Interest
Short Ratio2.1d
Short % Float4.66%
Short % Out.4.47%
Shares Short538.53K
Short (prev mo.)322.42K
Technical
SMA 501.098 (-62.0%)
SMA 2003.742 (-88.9%)
Beta
S&P 52W Chg19.97%
Avg Vol (30d)741.81K
Avg Vol (10d)1.67M
Technical Indicators
RSI (14)17.4
MACD-0.1953
MACD Signal-0.1870
MACD Hist.-0.0083
BB Upper1.067 USD
BB Middle0.7374 USD
BB Lower0.4079 USD
BB Width89.37%
ATR (14)0.0989 USD
Vol Ratio (20d)0.54x